CARsgen wins first global approval of car T therapy for solid tumours European Pharmaceutical Review 11:33 Tue, 23 Jun
CARsgen’s Satri-Cel Gains World-First Approval In Gastric Cancer Scrip Pharma Intelligence 09:35 Tue, 23 Jun
CARsgen Announces Approval of Satri-cel, the World's First car T-Cell Therapy Product for Solid Tumors PR Newswire (Press Release) 12:26 Mon, 22 Jun
CARsgen Presents Allogeneic car T-cell Products CT0596 and CT1190B at Eha 2026 PR Newswire (Press Release) 01:19 Mon, 15 Jun
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting PR Newswire (Press Release) 01:19 Mon, 01 Jun
